Article Commentary: Empirical Antibiotic Treatment for Peritoneal Dialysis-Related Peritonitis: Can “One Size” Fit All?

Piraino B. Peritonitis as a complication of peritoneal dialysis. J Am Soc Nephrol 1998; 9: 1956–64.

Keane W.F. , Everett E.D. , Golper T.A. , Gokal R. , Halstenson C. , Kawaguchi Y. Peritoneal dialysis-related peritonitis treatment recommendations: 1993 update. Perit Dial Int 1993; 13: 14–28.

Keane W.F. , Alexander S.R. , Bailie G.R. , Boeschoten E. , Gokal R. , Golper T.A. Peritoneal dialysis-related peritonitis treatment recommendations: 1996 update. Perit Dial Int 1996; 16: 557–73.

Keane W.F. , Bailie G.R. , Boeschoten E. , Gokal R. , Golper T.A. , Holmes C.J. Adult peritoneal dialysis-related peritonitis treatment recommendations: 2000 update [Published erratum appears in Perit Dial Int 2000; 20: 828-9]. Perit Dial Int 2000; 20: 396–411.

Baker R.J. , Senior H. , Clemenger M. , Brown E.A. Empirical aminoglycosides for peritonitis do not affect residual renal function. Am J Kidney Dis 2003; 41: 670–5.

Lui S.L. , Cheng S.W. , Ng F. , Ng S. Y. , Wan K.M. , Yip T. Cefazolin + netilmicin vs. cefazolin + ceftazidime for treating CAPD peritonitis: effect on residual renal function. Kidney Int 2005; 68: 2375–80.

Piraino B. , Bailie G.R. , Bernardini J. , Boeschoten E. , Gupta A. , Holmes C. Peritoneal dialysis-related infections recommendations: 2005 update. Perit Dial Int 2005; 25: 107–31.

Nikolaidis P. Newer quinolones in the treatment of continuous ambulatory peritoneal dialysis (CAPD) related infections. Perit Dial Int 1990; 10: 127–33.

Fleming L.W. , Phillips G. , Stewart W.K. , Scott A.C. Oral ciprofloxacin in the treatment of peritonitis in patients on continuous ambulatory peritoneal dialysis. J Antimicrob Chemother 1990; 25: 441–8.

Tapson J.S. , Orr K.E. , George J.C. , Stansfield E. , Bint A.J. , Ward M.K. A comparison between oral ciprofloxacin and intraperitoneal vancomycin and netilmicin in CAPD peritonitis. J Antimicrob Chemother 1990; 26(Suppl F): 63–71.

Cheng I.K. , Chan C.Y. , Wong W. T. , Cheng S.W. , Ritchie C.W. , Cheung W.C. A randomized prospective comparison of oral versus intraperitoneal ciprofloxacin as the primary treatment of peritonitis complicating continuous ambulatory peritoneal dialysis. Perit Dial Int 1993; 13(Suppl 2): S351–4.

Cheng I.K.P. , Lui S.L. , Fang G.X. , Chau P.Y. , Cheng S.W. , Chiu F.H. A randomised prospective comparison of oral versus intraperitoneal ofloxacin as the primary treatment of CAPD peritonitis. Nephrology 1997; 3: 431–5.

Goffin E. , Herbiet L. , Pouthier D. , Pochet J.M. , Lafontaine J.J. , Christophe J.L. Vancomycin and ciprofloxacin: systemic antibiotic administration for peritoneal dialysis-associated peritonitis. Perit Dial Int 2004; 24: 433–9.

Lima R.C.S. , Barreira A. , Cardoso F.L. , Lima M.H.S. , Leite M Jr. Ciprofloxacin and cefazolin as a combination for empirical initial therapy of peritoneal dialysis-related peritonitis: five-year follow-up. Perit Dial Int 2007; 27: 56–60.

Leung C.B. , Szeto C.C. , Chow K.M. , Kwan B.C. , Wang A.Y. , Lui S.F. Cefazolin plus ceftazidime versus imipenem/cilastatin monotherapy for treatment of CAPD peritonitis–a randomized controlled trial. Perit Dial Int 2004; 24: 440–6.

Szeto C.C. , Chow K.M. , Leung C.B. , Wong T. Y. , Wu A.K. , Wang A.Y. The clinical course of pseudomonas peritonitis complicating peritoneal dialysis–a review of 104 cases. Kidney Int 2001; 59: 2309–15.

Yip T. , Tse K.C. , Lam M.F. , Tang S. , Li F.K. , Choy B.Y. Risk factors and outcomes of extended-spectrum beta-lactamase-producing E. coli peritonitis in CAPD patients. Perit Dial Int 2006; 26: 191–7.